Thomas J Guilmette1, Jerry J Sweet2, Nancy Hebben3,4, Deborah Koltai5, E Mark Mahone6, Brenda J Spiegler7, Kirk Stucky8,9, Michael Westerveld10. 1. Department of Psychology, Providence College; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA. 2. Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, IL, USA. 3. Department of Psychiatry, Harvard Medical School, Boston, MA, USA. 4. Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA, USA. 5. Department of Neurology, Duke University School of Medicine, Durham, NC, USA. 6. Department of Neuropsychology, Kennedy Krieger Institute; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 7. Private Practice, Toronto, ON, Canada. 8. Department of Behavioral Health, Hurley Medical Center, Hurley Medical Center, Flint, MI, USA. 9. Department of Medicine, Michigan State University, East Lansing, MI, USA. 10. Adventhealth Neuropsychology-Orlando, Adventhealth Medical Group, Adventhealth Children's Hospital, Orlando, FL, USA.
Abstract
Objectives: Descriptive labels of performance test scores are a critical component of communicating outcomes of neuropsychological and psychological evaluations. Yet, no universally accepted system exists for assigning qualitative descriptors to scores in specific ranges. In addition, the definition and use of the term "impairment" lacks specificity and consensus. Consequently, test score labels and the denotation of impairment are inconsistently applied by clinicians, creating confusion among consumers of neuropsychological services, including referral sources, trainees, colleagues, and the judicial system. To reduce this confusion, experts in clinical and forensic neuropsychological and psychological assessment convened in a consensus conference at the 2018 Annual Meeting of the American Academy of Clinical Neuropsychology (AACN). The goals of the consensus conference were to recommend (1) a system of qualitative labels to describe results from performance-based tests with normal and non-normal distributions and (2) a definition of impairment and its application in individual case determinations. Results: The goals of the consensus conference were met resulting in specific recommendations for the application of uniform labels for performance tests and for the definition of impairment, which are described in this paper. In addition, included in this consensus statement is a description of the conference process and the rationales for these recommendations.Conclusions/Importance: This consensus conference is the first formal attempt by the professional neuropsychological community to make recommendations for uniform performance test score labels and to advance a consistent definition of impairment. Using uniform descriptors and terms will reduce confusion and enhance report comprehensibility by the consumers of our reports as well as our trainees and colleagues.
Objectives: Descriptive labels of performance test scores are a critical component of communicating outcomes of neuropsychological and psychological evaluations. Yet, no universally accepted system exists for assigning qualitative descriptors to scores in specific ranges. In addition, the definition and use of the term "impairment" lacks specificity and consensus. Consequently, test score labels and the denotation of impairment are inconsistently applied by clinicians, creating confusion among consumers of neuropsychological services, including referral sources, trainees, colleagues, and the judicial system. To reduce this confusion, experts in clinical and forensic neuropsychological and psychological assessment convened in a consensus conference at the 2018 Annual Meeting of the American Academy of Clinical Neuropsychology (AACN). The goals of the consensus conference were to recommend (1) a system of qualitative labels to describe results from performance-based tests with normal and non-normal distributions and (2) a definition of impairment and its application in individual case determinations. Results: The goals of the consensus conference were met resulting in specific recommendations for the application of uniform labels for performance tests and for the definition of impairment, which are described in this paper. In addition, included in this consensus statement is a description of the conference process and the rationales for these recommendations.Conclusions/Importance: This consensus conference is the first formal attempt by the professional neuropsychological community to make recommendations for uniform performance test score labels and to advance a consistent definition of impairment. Using uniform descriptors and terms will reduce confusion and enhance report comprehensibility by the consumers of our reports as well as our trainees and colleagues.
Keywords:
Impairment; performance tests; qualitative descriptors; test score labels
Authors: Bonnie C Sachs; Gordon J Chelune; Stephen R Rapp; Ashley M Couto; James J Willard; Jeff D Williamson; Kaycee M Sink; Laura H Coker; Sarah A Gaussoin; Tanya R Gure; Alan J Lerner; Linda O Nichols; Carolyn H Still; Virginia G Wadley; Nicholas M Pajewski Journal: Clin Neuropsychol Date: 2021-09-01 Impact factor: 3.535
Authors: Nikki H Stricker; Teresa J Christianson; Emily S Lundt; Eva C Alden; Mary M Machulda; Julie A Fields; Walter K Kremers; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen Journal: J Int Neuropsychol Soc Date: 2020-08-20 Impact factor: 2.892
Authors: Emma Rhodes; Philip S Insel; Meryl A Butters; Ruth Morin; David Bickford; Duygu Tosun; Devon Gessert; Howie J Rosen; Paul Aisen; Rema Raman; Susan Landau; Andrew Saykin; Arthur Toga; Clifford R Jack; Michael W Weiner; Craig Nelson; Scott Mackin Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Tiina M Remes; Emma Hovén; Niina Ritari; Heli Pohjasniemi; Riina Puosi; Pekka M Arikoski; Mikko O Arola; Päivi M Lähteenmäki; Tuula R I Lönnqvist; Marja K Ojaniemi; V Pekka Riikonen; Kirsti H Sirkiä; Satu Winqvist; Heikki M J Rantala; Marika Harila; Arja H Harila-Saari Journal: Neurooncol Pract Date: 2021-01-22